This trial is evaluating whether Opening the Conversation will improve 2 primary outcomes and 8 secondary outcomes in patients with Gynecologic Cancers. Measurement will happen over the course of Baseline to 3 months post-intervention..
This trial requires 200 total participants across 2 different treatment groups
This trial involves 2 different treatments. Opening The Conversation is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Breast cancer is a disease which is caused by uncontrolled cell growth in the breast and is associated with the abnormal development of breast tissues. It is most commonly treated with drugs or other therapies. By 2014 more than 2 million new cases of breast cancer will be diagnosed. Breast cancer occurs in women in all cultures, including in Europe, in the United States and in developing countries.\n\nDiseases, conditions and conditions of the nervous system, as well as congenital and other abnormalities, are discussed.\n\n- The brain-blood-spinal cord barrier\nThe brain-blood-spinal cord barrier forms a very important structural feature of the innermost section of the skull and spinal cord.
Signs of breast cancer may include a nipple that is abnormally large, has lumpiness or a sudden painless tender mass. Nipple discharge may occur. Women need to seek out medical attention. The most commonly occurring stage of breast cancer is breast cancer. The signs, symptoms, and signs of breast cancer can cause distress.
There are multiple factors, both external and social, that can contribute to an increased risk of developing breast cancer, including genetics and environmental factors. The risk of developing breast cancer increases with the age of women. Additionally, the risk of developing breast cancer doubles for every five years that a woman has not already been diagnosed.
Many women will be diagnosed with late stage breast cancer requiring treatment that can in fact reduce breast cancer-related mortality dramatically. In the context of a population of women with early stage breast cancer, the possibility of curing the disease with conservative treatment strategies should be tested.
There is no cure for breast cancer, so treatment is focused on symptom management and may include surgery, radiation, chemotherapy, or targeted therapy and hormone therapy. The decision to treat depends on the staging of disease, patient factors, and quality of life considerations.
Findings from this study confirmed that an open dialogue about breast cancer is an effective strategy for making people more open to the fact of their diagnosis. They also demonstrated that women are open to discussion about their diagnosis of breast cancer and feel they can express their emotions to their health care providers without being stigmatized.
Advancing knowledge in the field of genetics and chemotherapy has lead to a significant increase in the survival rates for [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer). However, no specific gene that affects the prognosis of breast cancer has been found so far. As knowledge of genetics and treatment of cancer continues to evolve, a more specific gene that could lead to a more effective treatment of breast cancer would be an excellent contribution to the treatment.
I have never seen research on breast cancer. We all need the latest research to protect ourselves from the disease. If breast cancer was not diagnosed yet you can find it is good to go to the hospital to see what is being researched to see what can be done to avoid it in the future.
When compared with the standard disclosure approach, the SDT approach resulted in greater patient satisfaction with communication regarding the diagnosis. Patients were also more likely to discuss breast cancer treatment options with their physicians after they received the SDT disclosure.
Recent findings demonstrated that the use of simple, easy strategies to foster an opportunity to discuss breast cancer can result in a significant improvement in patient knowledge, perceptions and behaviours (such as mammography screening).
Breast cancer survivors and their loved ones expressed needs and requirements for disclosure of cancer from time A onwards. A discussion and decision to disclose the cancer happened in a majority of cases. The information was presented differently by different partners. Overall, information is not a problem.